TY  - JOUR
A1  - Aygören-Pürsün, Emel
A1  - Martinez Saguer, Inmaculada
A1  - Rusicke, Eva
A1  - Klingebiel, Thomas
A1  - Kreuz, Wolfhart
T1  - On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
T2  - Allergy, asthma and clinical immunology
N2  - Background: Manifestation of acute edema in hereditary angioedema (HAE) is characterized by interindividual and intraindividual variability in symptom expression over time. Flexible therapy options are needed. Methods: We describe and report on the outcomes of the highly individualized approach to HAE therapy practiced at our HAE center in Frankfurt (Germany). Results: The HAE center at the Frankfurt University Hospital currently treats 450 adults with HAE or AAE and 107 pediatric HAE patients with highly individualized therapeutic approaches. 73.9% of the adult patients treat HAE attacks by on-demand therapy with pasteurized pd C1-INH concentrate, 9.8% use additional prophylaxis with attenuated androgens, 1% of the total patient population in Frankfurt has been treated with Icatibant up to now. In addition adult and selected pediatric patients with a high frequency of severe attacks are instructed to apply individual replacement therapy (IRT) with pasteurized pd C1-INH concentrate. Improvement on Quality of Life items was shown for these patients compared to previous long-term danazol prophylaxis. Home treatment of HAE patients was developed in the Frankfurt HAE center in line with experiences in hemophilia therapy and has so far been implemented over a period of 28 years. At present 248 (55%) of the adult patients and 26 (24%) of the pediatric patients are practicing home treatment either as on demand or IRT treatment. Conclusions: In conclusion, the individualized home therapies provided by our HAE center, aim to limit the disruption to normal daily activities that occurs for many HAE patients. Furthermore, we seek to optimize the economic burden of the disease while offering a maximum quality of life to our patients.
Y1  - 2010
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7884
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30-78450
SN  - 1710-1492
SN  - 1710-1484
N1  - © 2010 Aygoren-Pursun et al. , licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License  http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
VL  - 6
IS  - 1, Art. 21
SP  - 1
EP  - 4
PB  - BioMed Central
CY  - London
ER  -